Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Human Stage Holdings (TSE:321A) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Human Stage Holdings EBITDA Margin % Related Terms
Human Stage Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Human Stage Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Stage Holdings EBITDA Margin % Chart
Human Stage Holdings Annual Data
Trend
Mar24
Mar25
Mar26
EBITDA Margin %
6.56
2.84
4.94
Human Stage Holdings Semi-Annual Data
Mar24
Sep24
Mar25
Sep25
Mar26
EBITDA Margin %
0.00
7.36
-1.74
8.05
1.66
TSE:321A vs HON, MMM: EBITDA Margin % Comparison
For the Conglomerates subindustry, Human Stage Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Stage Holdings EBITDA Margin % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Human Stage Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Human Stage Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Stage Holdings (TSE:321A) has a EBITDA Margin % of 1.66% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Human Stage Holdings and its competitors. This is 66% below median its historical median of 4.94. Over the past decade, Human Stage Holdings' EBITDA Margin % has ranged from 2.84 to 6.56.
Is Human Stage Holdings' EBITDA Margin % too high?
Human Stage Holdings' current EBITDA Margin % of 1.66% is 66% below median its 10-year median of 4.94. Over the past 10 years, this metric has ranged from a low of 2.84 to a high of 6.56. The Conglomerates industry median EBITDA Margin % is 12.24. Human Stage Holdings' value of 1.66% is 86.4% below this industry median. Overall, Human Stage Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Human Stage Holdings' EBITDA Margin % compare to HON and MMM?
Human Stage Holdings' EBITDA Margin % of 1.66% can be compared against companies in the Conglomerates industry. The industry median EBITDA Margin % is 12.24. Human Stage Holdings' value of 1.66% is 86.4% below this benchmark. Historically, Human Stage Holdings' own EBITDA Margin % has ranged from 2.84 to 6.56 over the past decade. While the company's 10-year median is 4.94 vs. the industry median of 12.24, Human Stage Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Conglomerates company?
The median EBITDA Margin % among Conglomerates companies is 12.24, based on 551 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Human Stage Holdings's current EBITDA Margin % of 1.66% is 86.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Human Stage Holdings and its competitors. For the Conglomerates industry, the median EBITDA Margin % is 12.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Stage Holdings's current EBITDA Margin % is 1.66%, which is 66% below median its own 10-year median of 4.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Stage Holdings stock overvalued right now?
Human Stage Holdings (TSE:321A) has a current EBITDA Margin % of 1.66%. The current EBITDA Margin % is 1.66%, which is 66% below median its 10-year median of 4.94 and 86.4% below the Conglomerates industry median of 12.24. Human Stage Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Human Stage Holdings (TSE:321A), the current EBITDA Margin % is 1.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Human Stage Holdings Corp is engaged in consulting services related to asset management and operation of group subsidiaries engaged in the temporary staffing business and real estate leasing business.
12GF Score
Get the complete analysis for TSE:321A
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:321A has been successfully added to your 
